nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—EDNRB—type 2 diabetes mellitus	0.233	0.528	CbGaD
Bosentan—EDNRA—type 2 diabetes mellitus	0.177	0.4	CbGaD
Bosentan—EDNRA—Irbesartan—type 2 diabetes mellitus	0.158	0.43	CbGbCtD
Bosentan—CYP3A4—type 2 diabetes mellitus	0.032	0.0724	CbGaD
Bosentan—ABCB11—Glyburide—type 2 diabetes mellitus	0.0307	0.0837	CbGbCtD
Bosentan—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0147	0.0399	CbGbCtD
Bosentan—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0134	0.0365	CbGbCtD
Bosentan—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0125	0.0339	CbGbCtD
Bosentan—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0106	0.0289	CbGbCtD
Bosentan—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0106	0.0289	CbGbCtD
Bosentan—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00979	0.0266	CbGbCtD
Bosentan—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00957	0.026	CbGbCtD
Bosentan—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00945	0.0257	CbGbCtD
Bosentan—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00865	0.0235	CbGbCtD
Bosentan—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00853	0.0232	CbGbCtD
Bosentan—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00804	0.0219	CbGbCtD
Bosentan—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0078	0.0212	CbGbCtD
Bosentan—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00771	0.021	CbGbCtD
Bosentan—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00682	0.0186	CbGbCtD
Bosentan—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00617	0.0168	CbGbCtD
Bosentan—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00543	0.0148	CbGbCtD
Bosentan—CYP2C9—Losartan—type 2 diabetes mellitus	0.00497	0.0135	CbGbCtD
Bosentan—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00467	0.0127	CbGbCtD
Bosentan—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00448	0.0122	CbGbCtD
Bosentan—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00448	0.0122	CbGbCtD
Bosentan—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00424	0.0115	CbGbCtD
Bosentan—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00316	0.00859	CbGbCtD
Bosentan—CYP3A4—Losartan—type 2 diabetes mellitus	0.00289	0.00786	CbGbCtD
Bosentan—EDNRB—islet of Langerhans—type 2 diabetes mellitus	0.000546	0.157	CbGeAlD
Bosentan—EDNRB—retina—type 2 diabetes mellitus	0.000467	0.135	CbGeAlD
Bosentan—EDNRB—pancreas—type 2 diabetes mellitus	0.000384	0.111	CbGeAlD
Bosentan—EDNRB—cortex of kidney—type 2 diabetes mellitus	0.000376	0.108	CbGeAlD
Bosentan—EDNRB—adipose tissue—type 2 diabetes mellitus	0.000348	0.1	CbGeAlD
Bosentan—EDNRA—cortex of kidney—type 2 diabetes mellitus	0.000311	0.0897	CbGeAlD
Bosentan—EDNRA—adipose tissue—type 2 diabetes mellitus	0.000288	0.083	CbGeAlD
Bosentan—EDNRB—liver—type 2 diabetes mellitus	0.000244	0.0704	CbGeAlD
Bosentan—ABCB11—liver—type 2 diabetes mellitus	0.000197	0.0568	CbGeAlD
Bosentan—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000108	0.0311	CbGeAlD
Bosentan—CYP3A4—kidney—type 2 diabetes mellitus	8.06e-05	0.0232	CbGeAlD
Bosentan—CYP2C9—liver—type 2 diabetes mellitus	6.68e-05	0.0193	CbGeAlD
Bosentan—CYP3A4—liver—type 2 diabetes mellitus	5.09e-05	0.0147	CbGeAlD
Bosentan—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	5.05e-05	0.000414	CcSEcCtD
Bosentan—Oedema—Metformin—type 2 diabetes mellitus	5.05e-05	0.000414	CcSEcCtD
Bosentan—Tinnitus—Ramipril—type 2 diabetes mellitus	5.04e-05	0.000414	CcSEcCtD
Bosentan—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	5.03e-05	0.000413	CcSEcCtD
Bosentan—Flushing—Ramipril—type 2 diabetes mellitus	5.02e-05	0.000412	CcSEcCtD
Bosentan—Angioedema—Losartan—type 2 diabetes mellitus	5.02e-05	0.000412	CcSEcCtD
Bosentan—Infection—Metformin—type 2 diabetes mellitus	5.01e-05	0.000411	CcSEcCtD
Bosentan—Insomnia—Valsartan—type 2 diabetes mellitus	5.01e-05	0.000411	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	4.99e-05	0.000409	CcSEcCtD
Bosentan—Paraesthesia—Valsartan—type 2 diabetes mellitus	4.98e-05	0.000408	CcSEcCtD
Bosentan—Arthralgia—Irbesartan—type 2 diabetes mellitus	4.97e-05	0.000408	CcSEcCtD
Bosentan—Chest pain—Irbesartan—type 2 diabetes mellitus	4.97e-05	0.000408	CcSEcCtD
Bosentan—Shock—Metformin—type 2 diabetes mellitus	4.96e-05	0.000407	CcSEcCtD
Bosentan—Insomnia—Orlistat—type 2 diabetes mellitus	4.95e-05	0.000406	CcSEcCtD
Bosentan—Anxiety—Irbesartan—type 2 diabetes mellitus	4.95e-05	0.000406	CcSEcCtD
Bosentan—Hypersensitivity—Glyburide—type 2 diabetes mellitus	4.95e-05	0.000406	CcSEcCtD
Bosentan—Nervous system disorder—Metformin—type 2 diabetes mellitus	4.95e-05	0.000406	CcSEcCtD
Bosentan—Thrombocytopenia—Metformin—type 2 diabetes mellitus	4.94e-05	0.000405	CcSEcCtD
Bosentan—Dyspnoea—Valsartan—type 2 diabetes mellitus	4.94e-05	0.000405	CcSEcCtD
Bosentan—Vertigo—Losartan—type 2 diabetes mellitus	4.93e-05	0.000405	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	4.93e-05	0.000405	CcSEcCtD
Bosentan—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	4.93e-05	0.000405	CcSEcCtD
Bosentan—Somnolence—Valsartan—type 2 diabetes mellitus	4.93e-05	0.000404	CcSEcCtD
Bosentan—Syncope—Losartan—type 2 diabetes mellitus	4.92e-05	0.000404	CcSEcCtD
Bosentan—Paraesthesia—Orlistat—type 2 diabetes mellitus	4.92e-05	0.000403	CcSEcCtD
Bosentan—Leukopenia—Losartan—type 2 diabetes mellitus	4.91e-05	0.000403	CcSEcCtD
Bosentan—Discomfort—Irbesartan—type 2 diabetes mellitus	4.91e-05	0.000403	CcSEcCtD
Bosentan—Skin disorder—Metformin—type 2 diabetes mellitus	4.9e-05	0.000402	CcSEcCtD
Bosentan—Immune system disorder—Ramipril—type 2 diabetes mellitus	4.89e-05	0.000401	CcSEcCtD
Bosentan—Hyperhidrosis—Metformin—type 2 diabetes mellitus	4.88e-05	0.0004	CcSEcCtD
Bosentan—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.88e-05	0.0004	CcSEcCtD
Bosentan—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	4.87e-05	0.0004	CcSEcCtD
Bosentan—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.86e-05	0.000399	CcSEcCtD
Bosentan—Dry mouth—Irbesartan—type 2 diabetes mellitus	4.86e-05	0.000399	CcSEcCtD
Bosentan—Palpitations—Losartan—type 2 diabetes mellitus	4.85e-05	0.000398	CcSEcCtD
Bosentan—Nausea—Glimepiride—type 2 diabetes mellitus	4.84e-05	0.000397	CcSEcCtD
Bosentan—Loss of consciousness—Losartan—type 2 diabetes mellitus	4.83e-05	0.000396	CcSEcCtD
Bosentan—Nausea—Sitagliptin—type 2 diabetes mellitus	4.82e-05	0.000396	CcSEcCtD
Bosentan—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.82e-05	0.000396	CcSEcCtD
Bosentan—Asthenia—Glyburide—type 2 diabetes mellitus	4.82e-05	0.000395	CcSEcCtD
Bosentan—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.82e-05	0.000395	CcSEcCtD
Bosentan—Anorexia—Metformin—type 2 diabetes mellitus	4.81e-05	0.000395	CcSEcCtD
Bosentan—Cough—Losartan—type 2 diabetes mellitus	4.79e-05	0.000393	CcSEcCtD
Bosentan—Urticaria—Gliclazide—type 2 diabetes mellitus	4.79e-05	0.000393	CcSEcCtD
Bosentan—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.78e-05	0.000393	CcSEcCtD
Bosentan—Fatigue—Valsartan—type 2 diabetes mellitus	4.78e-05	0.000392	CcSEcCtD
Bosentan—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.77e-05	0.000391	CcSEcCtD
Bosentan—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.77e-05	0.000391	CcSEcCtD
Bosentan—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	4.76e-05	0.000391	CcSEcCtD
Bosentan—Oedema—Irbesartan—type 2 diabetes mellitus	4.76e-05	0.000391	CcSEcCtD
Bosentan—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.76e-05	0.000391	CcSEcCtD
Bosentan—Pruritus—Glyburide—type 2 diabetes mellitus	4.75e-05	0.00039	CcSEcCtD
Bosentan—Mental disorder—Ramipril—type 2 diabetes mellitus	4.74e-05	0.000389	CcSEcCtD
Bosentan—Constipation—Valsartan—type 2 diabetes mellitus	4.74e-05	0.000389	CcSEcCtD
Bosentan—Infection—Irbesartan—type 2 diabetes mellitus	4.73e-05	0.000388	CcSEcCtD
Bosentan—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	4.73e-05	0.000388	CcSEcCtD
Bosentan—Fatigue—Orlistat—type 2 diabetes mellitus	4.72e-05	0.000387	CcSEcCtD
Bosentan—Hypotension—Metformin—type 2 diabetes mellitus	4.71e-05	0.000387	CcSEcCtD
Bosentan—Erythema—Ramipril—type 2 diabetes mellitus	4.71e-05	0.000386	CcSEcCtD
Bosentan—Malnutrition—Ramipril—type 2 diabetes mellitus	4.71e-05	0.000386	CcSEcCtD
Bosentan—Shock—Irbesartan—type 2 diabetes mellitus	4.68e-05	0.000384	CcSEcCtD
Bosentan—Pain—Orlistat—type 2 diabetes mellitus	4.68e-05	0.000384	CcSEcCtD
Bosentan—Arthralgia—Losartan—type 2 diabetes mellitus	4.67e-05	0.000384	CcSEcCtD
Bosentan—Chest pain—Losartan—type 2 diabetes mellitus	4.67e-05	0.000384	CcSEcCtD
Bosentan—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.67e-05	0.000383	CcSEcCtD
Bosentan—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	4.67e-05	0.000383	CcSEcCtD
Bosentan—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.66e-05	0.000383	CcSEcCtD
Bosentan—Anxiety—Losartan—type 2 diabetes mellitus	4.66e-05	0.000382	CcSEcCtD
Bosentan—Tachycardia—Irbesartan—type 2 diabetes mellitus	4.65e-05	0.000381	CcSEcCtD
Bosentan—Rash—Bromocriptine—type 2 diabetes mellitus	4.63e-05	0.00038	CcSEcCtD
Bosentan—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.63e-05	0.00038	CcSEcCtD
Bosentan—Skin disorder—Irbesartan—type 2 diabetes mellitus	4.63e-05	0.00038	CcSEcCtD
Bosentan—Discomfort—Losartan—type 2 diabetes mellitus	4.62e-05	0.000379	CcSEcCtD
Bosentan—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.6e-05	0.000378	CcSEcCtD
Bosentan—Headache—Bromocriptine—type 2 diabetes mellitus	4.6e-05	0.000378	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.6e-05	0.000377	CcSEcCtD
Bosentan—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.6e-05	0.000377	CcSEcCtD
Bosentan—Dry mouth—Losartan—type 2 diabetes mellitus	4.57e-05	0.000375	CcSEcCtD
Bosentan—Anorexia—Irbesartan—type 2 diabetes mellitus	4.54e-05	0.000373	CcSEcCtD
Bosentan—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.53e-05	0.000372	CcSEcCtD
Bosentan—Paraesthesia—Metformin—type 2 diabetes mellitus	4.53e-05	0.000372	CcSEcCtD
Bosentan—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.53e-05	0.000371	CcSEcCtD
Bosentan—Dyspnoea—Metformin—type 2 diabetes mellitus	4.5e-05	0.000369	CcSEcCtD
Bosentan—Somnolence—Metformin—type 2 diabetes mellitus	4.49e-05	0.000368	CcSEcCtD
Bosentan—Oedema—Losartan—type 2 diabetes mellitus	4.48e-05	0.000368	CcSEcCtD
Bosentan—Anaphylactic shock—Losartan—type 2 diabetes mellitus	4.48e-05	0.000368	CcSEcCtD
Bosentan—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.48e-05	0.000367	CcSEcCtD
Bosentan—Infection—Losartan—type 2 diabetes mellitus	4.45e-05	0.000365	CcSEcCtD
Bosentan—Hypotension—Irbesartan—type 2 diabetes mellitus	4.45e-05	0.000365	CcSEcCtD
Bosentan—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.44e-05	0.000365	CcSEcCtD
Bosentan—Dyspepsia—Metformin—type 2 diabetes mellitus	4.44e-05	0.000365	CcSEcCtD
Bosentan—Tremor—Ramipril—type 2 diabetes mellitus	4.41e-05	0.000362	CcSEcCtD
Bosentan—Shock—Losartan—type 2 diabetes mellitus	4.41e-05	0.000362	CcSEcCtD
Bosentan—Urticaria—Valsartan—type 2 diabetes mellitus	4.4e-05	0.000361	CcSEcCtD
Bosentan—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.39e-05	0.000361	CcSEcCtD
Bosentan—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.39e-05	0.00036	CcSEcCtD
Bosentan—Decreased appetite—Metformin—type 2 diabetes mellitus	4.39e-05	0.00036	CcSEcCtD
Bosentan—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.38e-05	0.000359	CcSEcCtD
Bosentan—Tachycardia—Losartan—type 2 diabetes mellitus	4.37e-05	0.000359	CcSEcCtD
Bosentan—Nausea—Bromocriptine—type 2 diabetes mellitus	4.36e-05	0.000358	CcSEcCtD
Bosentan—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.36e-05	0.000358	CcSEcCtD
Bosentan—Fatigue—Metformin—type 2 diabetes mellitus	4.35e-05	0.000357	CcSEcCtD
Bosentan—Urticaria—Orlistat—type 2 diabetes mellitus	4.35e-05	0.000357	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.34e-05	0.000356	CcSEcCtD
Bosentan—Hyperhidrosis—Losartan—type 2 diabetes mellitus	4.33e-05	0.000356	CcSEcCtD
Bosentan—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.33e-05	0.000355	CcSEcCtD
Bosentan—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.33e-05	0.000355	CcSEcCtD
Bosentan—Asthenia—Gliclazide—type 2 diabetes mellitus	4.33e-05	0.000355	CcSEcCtD
Bosentan—Constipation—Metformin—type 2 diabetes mellitus	4.31e-05	0.000354	CcSEcCtD
Bosentan—Angioedema—Ramipril—type 2 diabetes mellitus	4.3e-05	0.000353	CcSEcCtD
Bosentan—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.28e-05	0.000351	CcSEcCtD
Bosentan—Anorexia—Losartan—type 2 diabetes mellitus	4.27e-05	0.000351	CcSEcCtD
Bosentan—Vomiting—Glyburide—type 2 diabetes mellitus	4.27e-05	0.00035	CcSEcCtD
Bosentan—Pruritus—Gliclazide—type 2 diabetes mellitus	4.27e-05	0.00035	CcSEcCtD
Bosentan—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.25e-05	0.000348	CcSEcCtD
Bosentan—Rash—Glyburide—type 2 diabetes mellitus	4.23e-05	0.000348	CcSEcCtD
Bosentan—Somnolence—Irbesartan—type 2 diabetes mellitus	4.23e-05	0.000347	CcSEcCtD
Bosentan—Dermatitis—Glyburide—type 2 diabetes mellitus	4.23e-05	0.000347	CcSEcCtD
Bosentan—Vertigo—Ramipril—type 2 diabetes mellitus	4.23e-05	0.000347	CcSEcCtD
Bosentan—Syncope—Ramipril—type 2 diabetes mellitus	4.22e-05	0.000347	CcSEcCtD
Bosentan—Leukopenia—Ramipril—type 2 diabetes mellitus	4.21e-05	0.000346	CcSEcCtD
Bosentan—Headache—Glyburide—type 2 diabetes mellitus	4.21e-05	0.000345	CcSEcCtD
Bosentan—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.19e-05	0.000344	CcSEcCtD
Bosentan—Hypotension—Losartan—type 2 diabetes mellitus	4.19e-05	0.000344	CcSEcCtD
Bosentan—Palpitations—Ramipril—type 2 diabetes mellitus	4.16e-05	0.000341	CcSEcCtD
Bosentan—Decreased appetite—Irbesartan—type 2 diabetes mellitus	4.14e-05	0.00034	CcSEcCtD
Bosentan—Loss of consciousness—Ramipril—type 2 diabetes mellitus	4.14e-05	0.00034	CcSEcCtD
Bosentan—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.13e-05	0.000339	CcSEcCtD
Bosentan—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.13e-05	0.000339	CcSEcCtD
Bosentan—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	4.11e-05	0.000337	CcSEcCtD
Bosentan—Cough—Ramipril—type 2 diabetes mellitus	4.11e-05	0.000337	CcSEcCtD
Bosentan—Fatigue—Irbesartan—type 2 diabetes mellitus	4.11e-05	0.000337	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	4.08e-05	0.000335	CcSEcCtD
Bosentan—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.08e-05	0.000335	CcSEcCtD
Bosentan—Pain—Irbesartan—type 2 diabetes mellitus	4.07e-05	0.000334	CcSEcCtD
Bosentan—Constipation—Irbesartan—type 2 diabetes mellitus	4.07e-05	0.000334	CcSEcCtD
Bosentan—Insomnia—Losartan—type 2 diabetes mellitus	4.05e-05	0.000333	CcSEcCtD
Bosentan—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.03e-05	0.000331	CcSEcCtD
Bosentan—Paraesthesia—Losartan—type 2 diabetes mellitus	4.02e-05	0.00033	CcSEcCtD
Bosentan—Urticaria—Metformin—type 2 diabetes mellitus	4.01e-05	0.000329	CcSEcCtD
Bosentan—Arthralgia—Ramipril—type 2 diabetes mellitus	4.01e-05	0.000329	CcSEcCtD
Bosentan—Chest pain—Ramipril—type 2 diabetes mellitus	4.01e-05	0.000329	CcSEcCtD
Bosentan—Dyspnoea—Losartan—type 2 diabetes mellitus	4e-05	0.000328	CcSEcCtD
Bosentan—Anxiety—Ramipril—type 2 diabetes mellitus	3.99e-05	0.000328	CcSEcCtD
Bosentan—Nausea—Glyburide—type 2 diabetes mellitus	3.99e-05	0.000327	CcSEcCtD
Bosentan—Abdominal pain—Metformin—type 2 diabetes mellitus	3.99e-05	0.000327	CcSEcCtD
Bosentan—Dizziness—Gliclazide—type 2 diabetes mellitus	3.99e-05	0.000327	CcSEcCtD
Bosentan—Somnolence—Losartan—type 2 diabetes mellitus	3.98e-05	0.000327	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	3.98e-05	0.000327	CcSEcCtD
Bosentan—Asthenia—Valsartan—type 2 diabetes mellitus	3.98e-05	0.000326	CcSEcCtD
Bosentan—Discomfort—Ramipril—type 2 diabetes mellitus	3.96e-05	0.000325	CcSEcCtD
Bosentan—Dyspepsia—Losartan—type 2 diabetes mellitus	3.94e-05	0.000324	CcSEcCtD
Bosentan—Asthenia—Orlistat—type 2 diabetes mellitus	3.93e-05	0.000322	CcSEcCtD
Bosentan—Pruritus—Valsartan—type 2 diabetes mellitus	3.92e-05	0.000322	CcSEcCtD
Bosentan—Dry mouth—Ramipril—type 2 diabetes mellitus	3.92e-05	0.000322	CcSEcCtD
Bosentan—Decreased appetite—Losartan—type 2 diabetes mellitus	3.9e-05	0.00032	CcSEcCtD
Bosentan—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.89e-05	0.00032	CcSEcCtD
Bosentan—Pruritus—Orlistat—type 2 diabetes mellitus	3.87e-05	0.000318	CcSEcCtD
Bosentan—Fatigue—Losartan—type 2 diabetes mellitus	3.86e-05	0.000317	CcSEcCtD
Bosentan—Oedema—Ramipril—type 2 diabetes mellitus	3.84e-05	0.000315	CcSEcCtD
Bosentan—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	3.84e-05	0.000315	CcSEcCtD
Bosentan—Vomiting—Gliclazide—type 2 diabetes mellitus	3.83e-05	0.000315	CcSEcCtD
Bosentan—Pain—Losartan—type 2 diabetes mellitus	3.83e-05	0.000315	CcSEcCtD
Bosentan—Constipation—Losartan—type 2 diabetes mellitus	3.83e-05	0.000315	CcSEcCtD
Bosentan—Rash—Gliclazide—type 2 diabetes mellitus	3.8e-05	0.000312	CcSEcCtD
Bosentan—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.8e-05	0.000312	CcSEcCtD
Bosentan—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.79e-05	0.000311	CcSEcCtD
Bosentan—Urticaria—Irbesartan—type 2 diabetes mellitus	3.78e-05	0.00031	CcSEcCtD
Bosentan—Shock—Ramipril—type 2 diabetes mellitus	3.78e-05	0.00031	CcSEcCtD
Bosentan—Headache—Gliclazide—type 2 diabetes mellitus	3.78e-05	0.00031	CcSEcCtD
Bosentan—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.77e-05	0.000309	CcSEcCtD
Bosentan—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.76e-05	0.000309	CcSEcCtD
Bosentan—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.76e-05	0.000309	CcSEcCtD
Bosentan—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.76e-05	0.000309	CcSEcCtD
Bosentan—Tachycardia—Ramipril—type 2 diabetes mellitus	3.75e-05	0.000308	CcSEcCtD
Bosentan—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.75e-05	0.000307	CcSEcCtD
Bosentan—Skin disorder—Ramipril—type 2 diabetes mellitus	3.73e-05	0.000306	CcSEcCtD
Bosentan—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.71e-05	0.000305	CcSEcCtD
Bosentan—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.66e-05	0.000301	CcSEcCtD
Bosentan—Dizziness—Valsartan—type 2 diabetes mellitus	3.66e-05	0.000301	CcSEcCtD
Bosentan—Anorexia—Ramipril—type 2 diabetes mellitus	3.66e-05	0.000301	CcSEcCtD
Bosentan—Dizziness—Orlistat—type 2 diabetes mellitus	3.62e-05	0.000297	CcSEcCtD
Bosentan—Asthenia—Metformin—type 2 diabetes mellitus	3.62e-05	0.000297	CcSEcCtD
Bosentan—Hypotension—Ramipril—type 2 diabetes mellitus	3.59e-05	0.000295	CcSEcCtD
Bosentan—Nausea—Gliclazide—type 2 diabetes mellitus	3.58e-05	0.000294	CcSEcCtD
Bosentan—Pruritus—Metformin—type 2 diabetes mellitus	3.57e-05	0.000293	CcSEcCtD
Bosentan—Urticaria—Losartan—type 2 diabetes mellitus	3.56e-05	0.000292	CcSEcCtD
Bosentan—Abdominal pain—Losartan—type 2 diabetes mellitus	3.54e-05	0.000291	CcSEcCtD
Bosentan—Body temperature increased—Losartan—type 2 diabetes mellitus	3.54e-05	0.000291	CcSEcCtD
Bosentan—Vomiting—Valsartan—type 2 diabetes mellitus	3.52e-05	0.000289	CcSEcCtD
Bosentan—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.51e-05	0.000288	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.5e-05	0.000287	CcSEcCtD
Bosentan—Rash—Valsartan—type 2 diabetes mellitus	3.49e-05	0.000287	CcSEcCtD
Bosentan—Dermatitis—Valsartan—type 2 diabetes mellitus	3.49e-05	0.000286	CcSEcCtD
Bosentan—Vomiting—Orlistat—type 2 diabetes mellitus	3.48e-05	0.000286	CcSEcCtD
Bosentan—Insomnia—Ramipril—type 2 diabetes mellitus	3.48e-05	0.000285	CcSEcCtD
Bosentan—Headache—Valsartan—type 2 diabetes mellitus	3.47e-05	0.000285	CcSEcCtD
Bosentan—Diarrhoea—Metformin—type 2 diabetes mellitus	3.45e-05	0.000283	CcSEcCtD
Bosentan—Rash—Orlistat—type 2 diabetes mellitus	3.45e-05	0.000283	CcSEcCtD
Bosentan—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.45e-05	0.000283	CcSEcCtD
Bosentan—Dermatitis—Orlistat—type 2 diabetes mellitus	3.45e-05	0.000283	CcSEcCtD
Bosentan—Headache—Orlistat—type 2 diabetes mellitus	3.43e-05	0.000281	CcSEcCtD
Bosentan—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.43e-05	0.000281	CcSEcCtD
Bosentan—Asthenia—Irbesartan—type 2 diabetes mellitus	3.42e-05	0.00028	CcSEcCtD
Bosentan—Somnolence—Ramipril—type 2 diabetes mellitus	3.42e-05	0.00028	CcSEcCtD
Bosentan—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.38e-05	0.000278	CcSEcCtD
Bosentan—Pruritus—Irbesartan—type 2 diabetes mellitus	3.37e-05	0.000276	CcSEcCtD
Bosentan—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.34e-05	0.000274	CcSEcCtD
Bosentan—Dizziness—Metformin—type 2 diabetes mellitus	3.34e-05	0.000274	CcSEcCtD
Bosentan—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.32e-05	0.000272	CcSEcCtD
Bosentan—Fatigue—Ramipril—type 2 diabetes mellitus	3.31e-05	0.000272	CcSEcCtD
Bosentan—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.3e-05	0.000271	CcSEcCtD
Bosentan—Nausea—Valsartan—type 2 diabetes mellitus	3.29e-05	0.00027	CcSEcCtD
Bosentan—Constipation—Ramipril—type 2 diabetes mellitus	3.29e-05	0.00027	CcSEcCtD
Bosentan—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.26e-05	0.000267	CcSEcCtD
Bosentan—Nausea—Orlistat—type 2 diabetes mellitus	3.25e-05	0.000267	CcSEcCtD
Bosentan—Asthenia—Losartan—type 2 diabetes mellitus	3.22e-05	0.000264	CcSEcCtD
Bosentan—Vomiting—Metformin—type 2 diabetes mellitus	3.21e-05	0.000263	CcSEcCtD
Bosentan—Rash—Metformin—type 2 diabetes mellitus	3.18e-05	0.000261	CcSEcCtD
Bosentan—Dermatitis—Metformin—type 2 diabetes mellitus	3.18e-05	0.000261	CcSEcCtD
Bosentan—Pruritus—Losartan—type 2 diabetes mellitus	3.17e-05	0.00026	CcSEcCtD
Bosentan—Headache—Metformin—type 2 diabetes mellitus	3.16e-05	0.000259	CcSEcCtD
Bosentan—Dizziness—Irbesartan—type 2 diabetes mellitus	3.15e-05	0.000258	CcSEcCtD
Bosentan—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.14e-05	0.000258	CcSEcCtD
Bosentan—Diarrhoea—Losartan—type 2 diabetes mellitus	3.07e-05	0.000252	CcSEcCtD
Bosentan—Urticaria—Ramipril—type 2 diabetes mellitus	3.05e-05	0.000251	CcSEcCtD
Bosentan—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.04e-05	0.000249	CcSEcCtD
Bosentan—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.04e-05	0.000249	CcSEcCtD
Bosentan—Vomiting—Irbesartan—type 2 diabetes mellitus	3.03e-05	0.000248	CcSEcCtD
Bosentan—Rash—Irbesartan—type 2 diabetes mellitus	3e-05	0.000246	CcSEcCtD
Bosentan—Dermatitis—Irbesartan—type 2 diabetes mellitus	3e-05	0.000246	CcSEcCtD
Bosentan—Nausea—Metformin—type 2 diabetes mellitus	3e-05	0.000246	CcSEcCtD
Bosentan—Headache—Irbesartan—type 2 diabetes mellitus	2.98e-05	0.000245	CcSEcCtD
Bosentan—Dizziness—Losartan—type 2 diabetes mellitus	2.96e-05	0.000243	CcSEcCtD
Bosentan—Vomiting—Losartan—type 2 diabetes mellitus	2.85e-05	0.000234	CcSEcCtD
Bosentan—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.83e-05	0.000232	CcSEcCtD
Bosentan—Nausea—Irbesartan—type 2 diabetes mellitus	2.83e-05	0.000232	CcSEcCtD
Bosentan—Rash—Losartan—type 2 diabetes mellitus	2.83e-05	0.000232	CcSEcCtD
Bosentan—Dermatitis—Losartan—type 2 diabetes mellitus	2.82e-05	0.000232	CcSEcCtD
Bosentan—Headache—Losartan—type 2 diabetes mellitus	2.81e-05	0.00023	CcSEcCtD
Bosentan—Asthenia—Ramipril—type 2 diabetes mellitus	2.76e-05	0.000226	CcSEcCtD
Bosentan—Pruritus—Ramipril—type 2 diabetes mellitus	2.72e-05	0.000223	CcSEcCtD
Bosentan—Nausea—Losartan—type 2 diabetes mellitus	2.66e-05	0.000218	CcSEcCtD
Bosentan—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.63e-05	0.000216	CcSEcCtD
Bosentan—Dizziness—Ramipril—type 2 diabetes mellitus	2.54e-05	0.000209	CcSEcCtD
Bosentan—Vomiting—Ramipril—type 2 diabetes mellitus	2.44e-05	0.000201	CcSEcCtD
Bosentan—Rash—Ramipril—type 2 diabetes mellitus	2.42e-05	0.000199	CcSEcCtD
Bosentan—Dermatitis—Ramipril—type 2 diabetes mellitus	2.42e-05	0.000199	CcSEcCtD
Bosentan—Headache—Ramipril—type 2 diabetes mellitus	2.41e-05	0.000198	CcSEcCtD
Bosentan—Nausea—Ramipril—type 2 diabetes mellitus	2.28e-05	0.000187	CcSEcCtD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	9.56e-06	0.000147	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.54e-06	0.000147	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AK1—type 2 diabetes mellitus	9.39e-06	0.000145	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.36e-06	0.000144	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.34e-06	0.000144	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	9.28e-06	0.000143	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—C3—type 2 diabetes mellitus	9.15e-06	0.000141	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.92e-06	0.000137	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.92e-06	0.000137	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.73e-06	0.000134	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.71e-06	0.000134	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AGT—type 2 diabetes mellitus	8.7e-06	0.000134	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SLC5A4—type 2 diabetes mellitus	8.67e-06	0.000133	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—MAT1A—type 2 diabetes mellitus	8.67e-06	0.000133	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	8.63e-06	0.000133	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GNB3—type 2 diabetes mellitus	8.6e-06	0.000132	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.6e-06	0.000132	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—HMOX1—type 2 diabetes mellitus	8.56e-06	0.000132	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.55e-06	0.000132	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—LEP—type 2 diabetes mellitus	8.52e-06	0.000131	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—APOE—type 2 diabetes mellitus	8.52e-06	0.000131	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	8.47e-06	0.00013	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CAT—type 2 diabetes mellitus	8.45e-06	0.00013	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.42e-06	0.00013	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	8.4e-06	0.000129	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—RELA—type 2 diabetes mellitus	8.39e-06	0.000129	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPP1R3C—type 2 diabetes mellitus	8.37e-06	0.000129	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HBA2—type 2 diabetes mellitus	8.37e-06	0.000129	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—G6PC—type 2 diabetes mellitus	8.37e-06	0.000129	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ENPP1—type 2 diabetes mellitus	8.37e-06	0.000129	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ND1—type 2 diabetes mellitus	8.37e-06	0.000129	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—APOB—type 2 diabetes mellitus	8.2e-06	0.000126	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GCGR—type 2 diabetes mellitus	8.11e-06	0.000125	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.03e-06	0.000124	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTM1—type 2 diabetes mellitus	7.98e-06	0.000123	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	7.84e-06	0.000121	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—LPL—type 2 diabetes mellitus	7.83e-06	0.000121	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	7.81e-06	0.00012	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ADCY5—type 2 diabetes mellitus	7.67e-06	0.000118	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYTB—type 2 diabetes mellitus	7.66e-06	0.000118	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—OXCT1—type 2 diabetes mellitus	7.66e-06	0.000118	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.64e-06	0.000118	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GPX1—type 2 diabetes mellitus	7.64e-06	0.000118	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.6e-06	0.000117	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.57e-06	0.000117	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.52e-06	0.000116	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SRD5A1—type 2 diabetes mellitus	7.46e-06	0.000115	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CD36—type 2 diabetes mellitus	7.44e-06	0.000115	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PPP2CA—type 2 diabetes mellitus	7.35e-06	0.000113	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—INS—type 2 diabetes mellitus	7.28e-06	0.000112	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.16e-06	0.00011	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.16e-06	0.00011	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HSD17B3—type 2 diabetes mellitus	7.12e-06	0.00011	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ACACA—type 2 diabetes mellitus	7.12e-06	0.00011	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—STAR—type 2 diabetes mellitus	7.12e-06	0.00011	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.08e-06	0.000109	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—MTHFR—type 2 diabetes mellitus	7.05e-06	0.000109	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.04e-06	0.000108	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.04e-06	0.000108	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.01e-06	0.000108	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.94e-06	0.000107	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PPARA—type 2 diabetes mellitus	6.92e-06	0.000107	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	6.85e-06	0.000105	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	6.85e-06	0.000105	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	6.82e-06	0.000105	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	6.82e-06	0.000105	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—AGT—type 2 diabetes mellitus	6.7e-06	0.000103	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.69e-06	0.000103	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SRC—type 2 diabetes mellitus	6.6e-06	0.000102	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CALM1—type 2 diabetes mellitus	6.59e-06	0.000101	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	6.57e-06	0.000101	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	6.57e-06	0.000101	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—APOE—type 2 diabetes mellitus	6.57e-06	0.000101	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	6.49e-06	0.0001	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	6.49e-06	0.0001	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—APOA1—type 2 diabetes mellitus	6.49e-06	9.99e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	6.45e-06	9.94e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	6.45e-06	9.93e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.43e-06	9.89e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.38e-06	9.83e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.38e-06	9.83e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	6.34e-06	9.77e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	6.34e-06	9.77e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	6.34e-06	9.77e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	6.19e-06	9.54e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	6.15e-06	9.47e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—RELA—type 2 diabetes mellitus	6.01e-06	9.25e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	5.97e-06	9.18e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.9e-06	9.08e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	5.87e-06	9.04e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.78e-06	8.9e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	5.73e-06	8.82e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PPARG—type 2 diabetes mellitus	5.72e-06	8.81e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	5.72e-06	8.8e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	5.72e-06	8.8e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—INS—type 2 diabetes mellitus	5.61e-06	8.64e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	5.59e-06	8.6e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	5.58e-06	8.59e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	5.52e-06	8.5e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	5.52e-06	8.5e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	5.52e-06	8.5e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	5.52e-06	8.5e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	5.52e-06	8.5e-05	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.47e-06	8.42e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.42e-06	8.34e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	5.39e-06	8.31e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	5.39e-06	8.31e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	5.39e-06	8.31e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	5.39e-06	8.31e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.38e-06	8.29e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	5.35e-06	8.23e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	5.19e-06	7.99e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	5.17e-06	7.96e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALB—type 2 diabetes mellitus	5.14e-06	7.92e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.12e-06	7.89e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.07e-06	7.8e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	5.05e-06	7.78e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	5.05e-06	7.78e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	5.02e-06	7.74e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.97e-06	7.65e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	4.92e-06	7.58e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	4.92e-06	7.58e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PIK3R1—type 2 diabetes mellitus	4.92e-06	7.57e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—NOS3—type 2 diabetes mellitus	4.92e-06	7.57e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	4.87e-06	7.49e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	4.81e-06	7.4e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SRC—type 2 diabetes mellitus	4.72e-06	7.27e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	4.69e-06	7.23e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	4.69e-06	7.23e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	4.69e-06	7.23e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.6e-06	7.08e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	4.5e-06	6.93e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	4.5e-06	6.93e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PTGS2—type 2 diabetes mellitus	4.5e-06	6.93e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	4.49e-06	6.91e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL6—type 2 diabetes mellitus	4.44e-06	6.84e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	4.4e-06	6.77e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	4.4e-06	6.77e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	4.33e-06	6.67e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	4.33e-06	6.67e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	4.31e-06	6.64e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.29e-06	6.6e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	4.29e-06	6.6e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	4.29e-06	6.6e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	4.29e-06	6.6e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	4.26e-06	6.56e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	4.26e-06	6.55e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.22e-06	6.5e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	4.18e-06	6.44e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	4.18e-06	6.44e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	4.18e-06	6.44e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	4.18e-06	6.44e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.14e-06	6.37e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	4.13e-06	6.37e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.1e-06	6.31e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	3.93e-06	6.06e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.86e-06	5.94e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	3.84e-06	5.92e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	3.84e-06	5.92e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	3.84e-06	5.92e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	3.77e-06	5.81e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	3.74e-06	5.76e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.69e-06	5.68e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	3.68e-06	5.67e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	3.66e-06	5.63e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	3.56e-06	5.48e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	3.56e-06	5.48e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	3.56e-06	5.48e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	3.56e-06	5.48e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	3.52e-06	5.41e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	3.48e-06	5.35e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	3.48e-06	5.35e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.41e-06	5.25e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	3.39e-06	5.22e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.37e-06	5.19e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	3.33e-06	5.13e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	3.33e-06	5.13e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL6—type 2 diabetes mellitus	3.18e-06	4.9e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.17e-06	4.88e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.96e-06	4.56e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.93e-06	4.52e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.9e-06	4.47e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.9e-06	4.47e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.87e-06	4.42e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.87e-06	4.42e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.86e-06	4.4e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.84e-06	4.38e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.83e-06	4.35e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.83e-06	4.35e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.83e-06	4.35e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.82e-06	4.34e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.81e-06	4.33e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.76e-06	4.25e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.74e-06	4.22e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.73e-06	4.2e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.66e-06	4.1e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.62e-06	4.03e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.56e-06	3.94e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.55e-06	3.93e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.54e-06	3.9e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.54e-06	3.9e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.54e-06	3.9e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.49e-06	3.83e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.48e-06	3.83e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.47e-06	3.8e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.45e-06	3.78e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.41e-06	3.72e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.35e-06	3.63e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.32e-06	3.57e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.31e-06	3.56e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.29e-06	3.53e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.29e-06	3.53e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—AKT1—type 2 diabetes mellitus	2.26e-06	3.48e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.24e-06	3.44e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.2e-06	3.39e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.2e-06	3.38e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.2e-06	3.38e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.19e-06	3.38e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.17e-06	3.34e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.91e-06	2.94e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.89e-06	2.92e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.89e-06	2.92e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.89e-06	2.9e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.87e-06	2.88e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.86e-06	2.87e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.81e-06	2.78e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.76e-06	2.71e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.72e-06	2.66e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.72e-06	2.64e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.69e-06	2.6e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.68e-06	2.59e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.64e-06	2.53e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.64e-06	2.53e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.64e-06	2.52e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.62e-06	2.49e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.55e-06	2.39e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.52e-06	2.35e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.5e-06	2.31e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.48e-06	2.27e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.45e-06	2.23e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.45e-06	2.23e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.43e-06	2.2e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.26e-06	1.94e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.24e-06	1.9e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.13e-06	1.74e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.08e-06	1.67e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.08e-06	1.67e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	9.91e-07	1.53e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	7.55e-07	1.16e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	4.98e-07	7.67e-06	CbGpPWpGaD
